<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinicopathologic analyses were done on 10 patients with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> including 8 patients with low grade <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The complete response rate to chemo- and combined modality therapy was 80% with no <z:hpo ids='HP_0011420'>deaths</z:hpo> occurring in patients in complete remission with median follow-up of 73 months </plain></SENT>
<SENT sid="2" pm="."><plain>The 5-years' survival for these 10 patients was 86% </plain></SENT>
<SENT sid="3" pm="."><plain>There were two patients with second primary <z:hpo ids='HP_0002664'>neoplasm</z:hpo>, one with <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> detected one year after initiation of chemotherapy, the other with <z:hpo ids='HP_0100243'>leiomyosarcoma</z:hpo> detected 3 years after cessation of chemotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>Histologic transformation from follicular medium sized cell to diffuse large cell was noted in one patient </plain></SENT>
</text></document>